The FDA has approved the first abuse-deterrent, immediate-release, 10 mg opioid tablet for pain management, signing off on another dosage of Protega Pharmaceuticals’ Roxybond. The nod covers those ...
Recent market analyses reveal a promising trajectory for the global opioid analgesics market, forecasting significant growth to USD 72.0 billion by 2033, with a robust Compound Annual Growth Rate ...